Progenra
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
277 Great Valley Pkwy, Malvern, Pennsylv...Phone Number
(610) 644-6974Website
www.progenra.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Progenra
Progenra is focused on developing new medicines by targeting the Ubiquitin Proteasome System, addressing unmet needs in various therapeutic areas including neurodegenerative diseases, cardiovascular disorders, and metabolic dysfunction. Their innovative UbiPro platform utilizes molecular glues and targeted protein degradation to create first-in-class therapeutics. The company aims to redefine treatment paradigms and improve patient care through its robust drug discovery engine. Progenra actively seeks partnerships to advance its pipeline of transformative therapies.Explore more
Progenra Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Progenra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Progenra, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Progenra has new funding data
Check out if Progenra is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Progenra recently announced quarterly report
Click to see if Progenra had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Progenra launches new products
Check if Progenra has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Progenra
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Progenra
Compare insights from companies similar to Progenra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Progenra is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Progenra is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Progenra.
Progenra financials insights
Gather financial insights about Progenra, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$180K
Progenra Tech Stack
A closer look at the technologies used by Progenra
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
Event
Events
Facilities Relocation / Expansion
Progenra is planning to move offices in May 2024. The move will impact approximately 1019 employees at the existing office located at 277 Great Valley Pkwy, Malvern, PA.
Facilities Relocation/Expansion
Funding
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Progenra
Sign Up For FreeTo access detailed company insights
Progenra is focused on developing new medicines by targeting the Ubiquitin Proteasome System, addressing unmet needs in various therapeutic areas including neurodegenerative diseases, cardiovascular disorders, and metabolic dysfunction. Their innovative UbiPro platform utilizes molecular glues and targeted protein degradation to create first-in-cla... Read More
